Trials
Search / Trial NCT05661279

Rhomboid Intercostal Block Versus Serratus Anterior Plane Block

Launched by ZAGAZIG UNIVERSITY · Dec 21, 2022

Trial Information

Current as of January 16, 2025

Recruiting

Keywords

Rhomboid Intercostal Block Serratus Anterior Plane Block Thoracodorsal Artery Perforator Flap

ClinConnect Summary

This clinical trial is studying two different methods of pain relief after a specific type of breast surgery called a thoracodorsal artery perforator flap following a partial mastectomy. The researchers want to see which method—called the rhomboid intercostal block or the serratus anterior plane block—works better to help manage postoperative (after surgery) pain. Both techniques use ultrasound (a type of imaging) to guide the injection of medication that numbs the area.

To participate in this trial, individuals need to be between 21 and 60 years old and scheduled for the specific breast surgery mentioned. They should also be in good overall health, without serious heart or lung conditions, and should not be taking certain medications like blood thinners or have allergies to local anesthesia. If eligible, participants can expect to receive one of the two pain relief methods, and their recovery experience will be monitored to see how effective the pain management is. This study is currently looking for volunteers who meet these criteria.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients aged between 21 to 60 years
  • Undergoing pedicled thoracodorsal artery perforator flap following breast conserving surgery -General anesthesia
  • Informed consents
  • ASA I \& II
  • Body mass index 25-30 kg/m2.
  • Exclusion Criteria:
  • patients on anti-platelet, anticoagulant or B blocker drugs
  • Patients with acute decompensated heart failure, hypertension, heart block, coronary disease, Asthma, bleeding disorders, compromised renal or hepatic function
  • history of allergy to local anesthesia or opioid analgesia,
  • pregnancy.

Trial Officials

Heba M Fathi

Principal Investigator

faculty of human medicine ,zagazig university

About Zagazig University

Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.

Locations

Zagazig, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials